Terms: = Ovarian cancer AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254
22 results:
1. De novo generation of the npm-ALK fusion recapitulates the pleiotropic phenotypes of ALK+ ALCL pathogenesis and reveals the ROR2 receptor as target for tumor cells.
Babin L; Darchen A; Robert E; Aid Z; Borry R; Soudais C; Piganeau M; De Cian A; Giovannangeli C; Bawa O; Rigaud C; Scoazec JY; Couronné L; Veleanu L; Cieslak A; Asnafi V; Sibon D; Lamant L; Meggetto F; Mercher T; Brunet E
Mol Cancer; 2022 Mar; 21(1):65. PubMed ID: 35246138
[TBL] [Abstract] [Full Text] [Related]
2. TERT Gene Fusions Characterize a Subset of Metastatic Leydig Cell Tumors.
Kruslin B; Gatalica Z; Hes O; Skenderi F; Miettinen M; Contreras E; Xiu J; Ellis M; Florento E; Vranic S; Swensen J
Clin Genitourin Cancer; 2021 Aug; 19(4):333-338. PubMed ID: 33741265
[TBL] [Abstract] [Full Text] [Related]
3. Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer.
Ma Y; Wang X; Qiu C; Qin J; Wang K; Sun G; Jiang D; Li J; Wang L; Shi J; Wang P; Ye H; Dai L; Jiang BH; Zhang J
Cancer Sci; 2021 Feb; 112(2):537-549. PubMed ID: 33185955
[TBL] [Abstract] [Full Text] [Related]
4. Incidental lymphoma in lymph node dissection for carcinoma in the abdominopelvic cavity: a single-institution experience.
Huang Y; Yan S; Liu L; Lu J; Yang X; He Y; Yun J
Virchows Arch; 2019 Sep; 475(3):365-372. PubMed ID: 31044268
[TBL] [Abstract] [Full Text] [Related]
5. Expression of CD24 in plasma, exosome and ovarian tissue samples of serous ovarian cancer patients.
Soltész B; Lukács J; Szilágyi E; Márton É; Szilágyi Bónizs M; Penyige A; Póka R; Nagy B
J Biotechnol; 2019 Jun; 298():16-20. PubMed ID: 30959137
[TBL] [Abstract] [Full Text] [Related]
6. A novel long non-coding RNA from NBL2 pericentromeric macrosatellite forms a perinucleolar aggregate structure in colon cancer.
Dumbovic G; Biayna J; Banús J; Samuelsson J; Roth A; Diederichs S; Alonso S; Buschbeck M; Perucho M; Forcales SV
Nucleic Acids Res; 2018 Jun; 46(11):5504-5524. PubMed ID: 29912433
[TBL] [Abstract] [Full Text] [Related]
7. The expression profile and prognostic value of APE/Ref-1 and npm1 in high-grade serous ovarian adenocarcinoma.
Fan X; Wen L; Li Y; Lou L; Liu W; Zhang J
APMIS; 2017 Oct; 125(10):857-862. PubMed ID: 28766835
[TBL] [Abstract] [Full Text] [Related]
8. Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer.
Sun H; Shi JX; Zhang HF; Xing MT; Li P; Dai LP; Luo CL; Wang X; Wang P; Ye H; Li LX; Zhang JY
Tumour Biol; 2017 Jun; 39(6):1010428317699132. PubMed ID: 28618923
[TBL] [Abstract] [Full Text] [Related]
9. Somatic mosaic mutations of IDH1 and npm1 associated with cup-like acute myeloid leukemia in a patient with Maffucci syndrome.
Akiyama M; Yamaoka M; Mikami-Terao Y; Ohyama W; Yokoi K; Arakawa Y; Takita J; Suzuki H; Yamada H
Int J Hematol; 2015 Dec; 102(6):723-8. PubMed ID: 26508204
[TBL] [Abstract] [Full Text] [Related]
10. Inhibitors of the apurinic/apyrimidinic endonuclease 1 (APE1)/nucleophosmin (npm1) interaction that display anti-tumor properties.
Poletto M; Malfatti MC; Dorjsuren D; Scognamiglio PL; Marasco D; Vascotto C; Jadhav A; Maloney DJ; Wilson DM; Simeonov A; Tell G
Mol Carcinog; 2016 May; 55(5):688-704. PubMed ID: 25865359
[TBL] [Abstract] [Full Text] [Related]
11. Regulatory role of nucleophosmin during the differentiation of human liver cancer cells.
Xu DH; Liu F; Li X; Chen XF; Jing GJ; Wu FY; Shi SL; Li QF
Int J Oncol; 2014 Jul; 45(1):264-72. PubMed ID: 24787960
[TBL] [Abstract] [Full Text] [Related]
12. Expression and prognostic significance of APE1/Ref-1 and npm1 proteins in high-grade ovarian serous cancer.
Londero AP; Orsaria M; Tell G; Marzinotto S; Capodicasa V; Poletto M; Vascotto C; Sacco C; Mariuzzi L
Am J Clin Pathol; 2014 Mar; 141(3):404-14. PubMed ID: 24515769
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of candidate serologic markers for type I and type II ovarian cancer.
Lu D; Kuhn E; Bristow RE; Giuntoli RL; Kjær SK; Shih IeM; Roden RB
Gynecol Oncol; 2011 Sep; 122(3):560-6. PubMed ID: 21704359
[TBL] [Abstract] [Full Text] [Related]
14. BRCA2 and nucleophosmin coregulate centrosome amplification and form a complex with the Rho effector kinase ROCK2.
Wang HF; Takenaka K; Nakanishi A; Miki Y
Cancer Res; 2011 Jan; 71(1):68-77. PubMed ID: 21084279
[TBL] [Abstract] [Full Text] [Related]
15. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.
Nishikawa H; Wu W; Koike A; Kojima R; Gomi H; Fukuda M; Ohta T
Cancer Res; 2009 Jan; 69(1):111-9. PubMed ID: 19117993
[TBL] [Abstract] [Full Text] [Related]
16. Comparative genomics on FGF8, FGF17, and FGF18 orthologs.
Katoh M; Katoh M
Int J Mol Med; 2005 Sep; 16(3):493-6. PubMed ID: 16077960
[TBL] [Abstract] [Full Text] [Related]
17. Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2.
Hayami R; Sato K; Wu W; Nishikawa T; Hiroi J; Ohtani-Kaneko R; Fukuda M; Ohta T
Cancer Res; 2005 Jan; 65(1):6-10. PubMed ID: 15665273
[TBL] [Abstract] [Full Text] [Related]
18. Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects.
Taylor DD; Gerçel-Taylor C
Br J Cancer; 2005 Jan; 92(2):305-11. PubMed ID: 15655551
[TBL] [Abstract] [Full Text] [Related]
19. Pre-counseling education materials for BRCA testing: does tailoring make a difference?
Skinner CS; Schildkraut JM; Berry D; Calingaert B; Marcom PK; Sugarman J; Winer EP; Iglehart JD; Futreal PA; Rimer BK
Genet Test; 2002; 6(2):93-105. PubMed ID: 12215248
[TBL] [Abstract] [Full Text] [Related]
20. Initiation of translation from a downstream in-frame AUG codon on BRCA1 can generate the novel isoform protein DeltaBRCA1(17aa).
Liu J; Prolla G; Rostagno A; Chiarle R; Feiner H; Inghirami G
Oncogene; 2000 May; 19(23):2767-73. PubMed ID: 10851077
[TBL] [Abstract] [Full Text] [Related]
[Next]
